Company / Current Assets
Wave Life Sciences Ltd. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$614.8M
FY2025
5-year range
$98.5M / $614.8M
FY2021-FY2025
Trend
+91.9%
vs FY2024
Sector context
#96 of 213
Health Care
What the data says
At $615M, Wave Life Sciences Ltd.'s current assets ranks #96 of 213 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $99M in FY2022 to $615M in FY2025.
Based on SEC 10-K filings.
$615M in FY2025 with a 5-year CAGR of +21.7%.
Improved from $235M to $615M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +84.1%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
#96 of 213 in Health CareTop 45% of 213This company $614.8M Sector average $2.5B
▼
-75.6% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +21.7%, indicating consistent growth.
- In FY2025, current assets increased 91.9% year-over-year.
- Ranks #96 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $614.8M | +91.9% |
| FY2024 | $320.4M | +36.1% |
| FY2023 | $235.4M | +138.9% |
| FY2022 | $98.5M | -39.4% |
| FY2021 | $162.6M | -29.3% |
| FY2020 | $230.0M | +24.0% |
| FY2019 | $185.5M | -8.3% |
| FY2018 | $202.3M | +34.4% |
| FY2017 | $150.5M | -1.0% |
| FY2016 | $152.0M | -5.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026